ArticleInternal and emergency medicine2025
Patterns of heated tobacco product use and biochemically verified smoking status among customers of dedicated heated tobacco product stores.
Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Influence of heat-non-burn tobacco aerosol on the microbiome of biofilm from human whole saliva bacteria in vitro.Clinical oral investigations · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To understand the population impact of heated tobacco products (HTPs), examining the profile of their users is crucial. This study aimed to assess characteristics, patterns of HTP use, and biochemically verified smoking status of customers visiting specialized HTP stores in Greece. Two specialized stores selling IQOS HTPs were randomly selected in Athens. Researchers recruited consecutive adult customers purchasing products for personal use during store visits. Current smoking status was determined by measuring exhaled carbon monoxide (eCO), with ≥ 7 ppm classifying participants as current smokers. A questionnaire explored demographics, past and current smoking history, HTP use patterns, and dependence indicators. A total of 373 HTP users participated. The vast majority (98.1%) had a smoking history prior to HTP initiation. Former smokers represented 67.8% of the study sample, defined based on self-report and having eCO < 7 ppm, with 90.1% of them reporting they had quit with the use of HTPs. Current smokers represented 30.3% of the sample and reported a 50% median reduction in daily cigarette consumption post-HTP use initiation. Never-smokers represented 1.9% of the sample, all of whom had eCO ≤ 3 ppm. Daily HTP use was the predominant pattern of use in both groups, but was more prevalent among former smokers. Most participants perceived HTPs as less harmful than cigarettes. From logistic regression analysis, factors associated with being a former smoker were HTP use duration (OR: 1.06, 95% CI 1.02-1.09) and daily HTP use (OR: 6.93, 95% CI 1.93-24.92). Customers of specialized HTP stores in Greece were predominantly individuals with a history of smoking. A substantial proportion was biochemically verified former smokers and reported they had quit with the help of HTPs. Use by never-smokers was rare in this retail setting, and did not lead to subsequent smoking.
Indexed as
Identifiers
40576934What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.